ArticleTechnology in cancer research & treatment

Clinical Value of Human Endogenous Retrovirus-H Long Terminal Repeat Associating 2 (HHLA2) in Small Cell Lung Cancer.

Xiuqin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.